Given that proliferation response to 3-Epi and cisplatin seems to be related to Pit-1 levels in breast cancer cell lines, fifteen primary cultures from human breast tumors were used to evaluate the effect of 3-Epi and cisplatin (Supplementary Table S1). The gene discussed is POU1F1; the disease is breast cancer.